In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Jennifer Meade, president of the breast and skeletal health division at Hologic. She offers insight on the company’s recent acquisition activity as well as its partnership involving artificial intelligence. Meade also speaks to the importance of AI within Hologic technology and its efforts to encourage greater patient compliance. Specifically, the following questions are addressed.

• You were promoted to the position of president of the breast and skeletal health division in August of last year. What are your top priorities for your segment of Hologic in 2021 and beyond?
• Hologic didn’t waste time this year with an acquisition just a few days after the ball dropped on the new year. Can you speak to the reason behind the Somatex acquisition and where you see this fitting into your larger plan?
• It was announced last year that Hologic was working with RadNet on an artificial intelligence-based initiative. Can you tell me more about that?
• How is Hologic leveraging AI in other areas and technologies?
• Does Hologic see opportunities at the technology or device level to help increase compliance with regular breast cancer screenings?

Listen to this episode and see what you think of Hologic’s approach to addressing women’s breast health. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at [email protected].

Listen to the podcast streaming via the player or get the podcast on the Medtech Matters channel via your preferred vendor of podcasts, such as Apple Podcasts (iTunes) or Spotify.

Send us a text

For more medtech news and information, visit https://www.mpomag.com.